What is Bristol-Myers Squibb's revenue?

Bristol-Myers Squibb (BMY) generated $48.5B in revenue over the trailing twelve months, up 1.8% year over year.

Is Bristol-Myers Squibb profitable?

Bristol-Myers Squibb reported $7.3B in net income over the trailing twelve months, a 15.0% net margin.

What is Bristol-Myers Squibb's earnings per share?

Bristol-Myers Squibb's diluted EPS over the trailing twelve months is $3.56.

Where does Bristol-Myers Squibb's income statement data come from?

Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bristol-Myers Squibb BMY Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$11.49B-8.1%	$12.5B+2.3%	$12.22B-0.4%	$12.27B+9.5%	$11.2B-9.2%
Total cost of revenue	$3.42B-16.5%	$4.1B+19.3%	$3.44B+1.9%	$3.37B+11.2%	$3.03B-37.0%
Gross profit	$8.07B-4.0%	$8.41B-4.3%	$8.79B-1.2%	$8.9B+8.9%	$8.17B+8.5%
Gross margin	70.2%+3.0pp	67.2%-4.7pp	71.9%-0.6pp	72.5%-0.4pp	72.9%+11.9pp
Research and development	$2.65B+2.4%	$2.59B+2.3%	$2.53B-2.0%	$2.58B+14.3%	$2.26B-29.3%
Selling, general and administrative	$1.62B-25.9%	$2.18B+21.9%	$1.79B+4.4%	$1.71B+8.1%	$1.58B-25.8%
Total costs & expenses	$8.25B-25.2%	$11.03B+21.1%	$9.11B-13.2%	$10.5B+27.5%	$8.23B-32.4%
Income before income taxes	$3.24B+120%	$1.47B-52.8%	$3.11B+75.6%	$1.77B-40.3%	$2.97B—
Income tax expense	$561M+46.1%	$384M-58.2%	$919M+99.8%	$460M-9.6%	$509M+414%
Net income	$2.68B+146%	$1.09B-50.6%	$2.2B+68.0%	$1.31B-46.7%	$2.46B—
Net margin	23.3%+14.6pp	8.7%-9.3pp	18%+7.3pp	10.7%-11.2pp	21.9%+21.9pp
Diluted earnings per share	$1.31+147%	$0.53-50.9%	$1.08+68.8%	$0.64-46.7%	$1.20—
Basic earnings per share	$1.31+143%	$0.54-50.0%	$1.08+68.8%	$0.64-47.1%	$1.21—
Acquired IPRD	$94M-93.3%	$1.39B+120%	$633M-58.0%	$1.51B+702%	$188M+527%
Amortization of acquired intangible assets	$437M-47.1%	$826M-0.6%	$831M+0.1%	$830M0.0%	$830M-51.0%
Other income, net (Note 6)	-$32M—	$0-100%	$108M+122%	-$494M-45.7%	-$339M-11.1%
EBITDA	$3.83B+56.7%	$2.45B-40.7%	$4.13B+48.2%	$2.78B-30.1%	$3.98B+112%
EBITDA margin	33.4%+13.8pp	19.6%-14.2pp	33.8%+11.1pp	22.7%-12.9pp	35.6%+20.3pp
EBIT	$3.24B+120%	$1.47B-52.8%	$3.11B+75.6%	$1.77B-40.3%	$2.97B—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's revenue?: Bristol-Myers Squibb (BMY) generated $48.5B in revenue over the trailing twelve months, up 1.8% year over year.
Is Bristol-Myers Squibb profitable?: Bristol-Myers Squibb reported $7.3B in net income over the trailing twelve months, a 15.0% net margin.
What is Bristol-Myers Squibb's earnings per share?: Bristol-Myers Squibb's diluted EPS over the trailing twelve months is $3.56.
Where does Bristol-Myers Squibb's income statement data come from?: Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.